Costa A, Bescós M, Velho G, Chêvre J, Vidal J, Sesmilo G, Bellanné-Chantelot C, Froguel P, Casamitjana R, Rivera-Fillat F, Gomis R, Conget I
Servei d'Endocrinologia i Diabetis, IDIBAPS, Hospital Clínic, Facultat de Medicina, Universitat de Barcelona, Spain.
Eur J Endocrinol. 2000 Apr;142(4):380-6. doi: 10.1530/eje.0.1420380.
To investigate the frequencies of the major maturity-onset diabetes of the young (MODY) subtypes in a panel of Spanish families and to assess phenotypic differences in patients with the different subtypes of MODY.
Forty-eight subjects from twenty families with clinical diagnosis of MODY were studied. They underwent a standardised clinical examination and a 75-g oral glucose tolerance test (OGTT) was performed. Estimations of insulin sensitivity (%S) and insulin secretion capacity (%B) were calculated by the computer-solved homeostasis model assessment (HOMA). Mutations in the coding regions of hepatocyte nuclear factor (HNF)-4alpha/MODY1, glucokinase (GCK/MODY2) and HNF-1alpha/MODY3 genes were investigated by single strand comformation polymorphism and sequencing analysis.
Mutations in the GCK and HNF-1alpha genes were observed in 5 (25%) and 7 (35%) families respectively. Novel mutations included R385X, M238fsdelT, V226fsdelTinsAA and S418-7del11 in the GCK gene, and S121fsdelC, V133M, R159Q and V259D in the HNF-1alpha gene. No MODY1 families were found. Subjects which were neither MODY2 nor MODY3 (MODY-X) had a higher fasting glucose than subjects in the other groups. Insulin secretion capacity was similar in the three groups and the insulin sensitivity was decreased in MODY-X subjects. Glucose levels were significantly higher and insulin levels significantly lower, throughout the OGTT, in MODY3 compared with MODY2 subjects.
Mutations in the GCK/MODY2 and HNF-1alpha/MODY3 genes account for the majority of cases in a panel of Spanish MODY families, with MODY3 being the most frequent subtype. The relative frequencies and the clinical characteristics of these MODY subtypes are in agreement with data previously reported in other European populations. MODY-X patients seem to present a heterogeneous clinical profile.
在一组西班牙家庭中调查青年发病的成年型糖尿病(MODY)主要亚型的发生率,并评估不同MODY亚型患者的表型差异。
对来自20个临床诊断为MODY家庭的48名受试者进行研究。他们接受了标准化临床检查,并进行了75克口服葡萄糖耐量试验(OGTT)。通过计算机求解的稳态模型评估(HOMA)计算胰岛素敏感性(%S)和胰岛素分泌能力(%B)。通过单链构象多态性和测序分析研究肝细胞核因子(HNF)-4α/MODY1、葡萄糖激酶(GCK/MODY2)和HNF-1α/MODY3基因编码区的突变。
分别在5个(25%)和7个(35%)家庭中观察到GCK和HNF-1α基因突变。新的突变包括GCK基因中的R385X、M238fsdelT、V226fsdelTinsAA和S418-7del11,以及HNF-1α基因中的S121fsdelC、V133M、R159Q和V259D。未发现MODY1家庭。既非MODY2也非MODY3(MODY-X)的受试者空腹血糖高于其他组的受试者。三组的胰岛素分泌能力相似,MODY-X受试者的胰岛素敏感性降低。与MODY2受试者相比,MODY3受试者在整个OGTT过程中的血糖水平显著更高,胰岛素水平显著更低。
GCK/MODY2和HNF-1α/MODY3基因突变占一组西班牙MODY家庭中大多数病例,其中MODY3是最常见的亚型。这些MODY亚型的相对发生率和临床特征与先前在其他欧洲人群中报道的数据一致。MODY-X患者似乎呈现出异质性临床特征。